Prof. Wu Yi-Long
Lifetime Director, Guangdong Provincial People’s Hospital
Academic Profile
Professor Wu Yi-Long is the pioneer of precision lung cancer treatment in China, Lifetime Director of Guangdong Provincial People’s Hospital, Director of the Guangdong Lung Cancer Institute, and Chair of the Chinese Thoracic Oncology Group (CTONG). His study series have repeatedly rewritten international lung cancer guidelines.
He established the full-course management paradigm for EGFR-mutant lung cancer; studies such as ADJUVANT first established adjuvant targeted therapy, and he has long represented China at ASCO, WCLC and other international forums.
Appointments & Honors
- Former President, Chinese Society of Clinical Oncology (CSCO)
- Recipient of the IASLC Distinguished Scientific Award
- Principal investigator of trials that changed international lung cancer guidelines
Appointments
- Honorary Director, Guangdong Lung Cancer Institute
- Chair, Chinese Thoracic Oncology Group (CTONG)
- Past President, Oncology Branch of CMDA
- Former Board Member, IASLC
Areas of Expertise
- Precision targeted therapy for lung cancer
- Adjuvant therapy decisions in lung cancer
- Matching therapy for rare driver alterations
Academic Achievements
- ADJUVANT/CTONG1104 changed adjuvant practice for EGFR-mutant lung cancer
- Founded CTONG; multiple results incorporated into NCCN/ESMO guidelines
- Recipient of the Chinese Physician Award and Guangdong S&T awards
Selected Publications
Osimertinib in resected EGFR-mutated non-small-cell lung cancer (ADAURA)
New England Journal of Medicine · 2020
First author
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA EGFR-mutant NSCLC (ADJUVANT-CTONG1104)
The Lancet Oncology · 2018
Corresponding author
Cancer Focus
Precision Lung Cancer Care
Outpatient Schedule
| Mon AM · VIP Clinic |
| Wed AM · Lung Cancer MDT |
Schedules sync with the hospital’s official website daily at 00:00 CST. Actual availability is subject to the hospital’s same-day announcement.
Available Hospitals
CASE FEASIBILITY REVIEW
Submit Your Case for a Free Review
Share your contact details, confirmed diagnosis and main question. No medical files needed at this stage. A clinical coordinator will contact you within 24-48 hours.
- No medical file upload required at this stage
- By submitting you agree to our privacy policy. Your information is used solely for hospital assessment and transmitted encrypted.